Quality Metrics

For 30 years, PrimeCare Health has provided quality and affordable care to underserved communities in Chicago. Our multilingual providers and staff address unmet need by serving patients of all ages and helping them access our services. In 2022, we were named a Health Center Quality Leader by the Health Resources & Services Administration (HRSA). We were given this recognition for our high rates in clinical quality measures.

The previous year was our first time being recognized as a Health Center Quality Leader. We also received Community Health Center Quality Recognition (CQHR) badges in Target Blood Pressure, Statin Therapy, Target Type 2 Diabetes, Advancing HIT for Quality, and PCMH Recognition.

Although these awards are a great honor for our organization, we thank our dedicated staff and trusted patients who work together every day to foster positive health outcomes for more than 20,000 people across the northwest side of Chicago.

 
We had 31,984 patients in 2024. We are committed to the family medicine approach, which is based on a continuous, comprehensive, and holistic patient-provider relationship.
We had 105,292 visits to our centers in 2024. We seek to improve the health and wellbeing of all individuals & communities that we serve in partnership with aligned health and social service providers.
In 2024, 81% of our patients had public insurance or no insurance. We work with our patients to provide quality, affordable care to a medically underserved population.
92% DEPRESSION SCREENING & FOLLOW-UP

Patients aged 12+ with a visit in 2024 who were screened for depression and, if positive, have a follow-up plan documented.

92% WEIGHT ASSESSMENT KIDS

Patients aged 3-17 with a visit in 2024 and a documented BMI percentile, nutrition, and exercise counseling.

81% USE OF ANTIPLATELETS IN PATIENTS WITH IVD.

Patients with Ischemic Vascular Disease (IVD) with a visit in 2024 who were prescribed aspirin or other antiplatelets.

Patients aged 13+ with a visit in 2024 who were screened for tobacco use and, if positive, have a follow-up plan documented.

89% statin therapy to treat cardiovascular disease.

Patients aged 21+ at high risk of cardiovascular events who were prescribed a statin in 2024.

75% CERVICAL CANCER SCREENING.

Patients with a cervix aged 21-29, with a visit in 2024, who had PAP SMEAR within the last three years, or aged 30-64 with PAP SMEAR & HPV co-testing within the past 5 years.

63% breast cancer screening.

Women aged 51-73 with a visit in 2024 who had a mammogram

to screen for

breast cancer.

73% CONTROLLING HIGH BLOOD PRESSURE

Patients with hypertension with a visit in 2024 whose blood pressure was regulated to

<140/90 mmHg.

87% BMI SCREENING & FOLLOW-UP.

Patients with a visit in 2024 whose BMI was measured and, if overweight, had a follow-up plan documented.